About Xalud 

Xalud is derived from the word, Salud, meaning ‘safety’ in Latin and ‘good health’ in Spanish.


Founded in 2009 by three experienced scientists who joined forces to develop treatments for chronic inflammatory disease, Xalud Therapeutics is a non-viral gene therapy company targeting immune modulation. There is a large unmet need for treatments for chronic inflammatory disease that are efficacious and safe. Xalud’s mission is to harness the power of interleukin-10 (IL-10), a potent anti-inflammatory cytokine to address the root cause of inflammation and subsequently restore homeostasis in the immune system.


40 West 57th Street, Suite 1810 New York, NY 10019  |  hello@xaludthera.com